Anorectic actions of prolactin-releasing peptide are mediated by corticotropin-releasing hormone receptors

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 286, Issue 1 55-1, 2004, Pages

  Lawrence, Catherine B ^a   Liu, Yong Ling ^b   Stock, Michael J ^b   Luckman, Simon M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Astressin; Body temperature; Food intake; Oxygen consumption; SHU 9119

Indexed keywords

ALPHA INTERMEDIN; ASTRESSIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR; MELANOCORTIN; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NEUROPEPTIDE; PROLACTIN RELEASING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY TEMPERATURE; BODY WEIGHT; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; ENERGY EXPENDITURE; FOOD INTAKE; MALE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; RAT STRAIN;

EID: 0346096879     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00402.2003     Document Type: Article

References (60)

1. Baram TZ, Koutsoukos Y, Schultz L, and Rivier J. The effect of "Astressin," a novel antagonist of corticotropin releasing hormone (CRH), on CRH-induced seizures in the infant rat: comparison with two other antagonists. Mol Psychiatry 1: 223-226, 1996.
2. Chen C, Dun SL, Dun NJ, and Chang JK. Prolactin-releasing peptide-immunoreactivity in A1 and A2 noradrenergic neurons of the rat medulla. Brain Res 822: 276-279, 1999.
3. Diamant M and De Wied D. Autonomic and behavioral effects of centrally administered corticotropin-releasing factor in rats. Endocrinology 129: 446-454, 1991.
4. Ellacott KL, Lawrence CB, Pritchard LE, and Luckman SM. Repeated administration of the anorectic factor prolactin-releasing peptide leads to tolerance to its effects on energy homeostasis. Am J Physiol Regul Integr Comp Physiol 285: R1005-R1010, 2003.
5. Ellacott KL, Lawrence CB, Rothwell NJ, and Luckman SM. PRL-releasing peptide interacts with leptin to reduce food intake and body weight. Endocrinology 143: 368-374, 2002.
6. Fan W, Boston BA, Kesterson RA, Hruby VJ, and Cone RD. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385: 165-168, 1997.
7. Fujii R, Fukusumi S, Hosoya M, Kawamata Y, Habata Y, Hinuma S, Sekiguchi M, Kitada C, Kurokawa T, Nishimura O, Onda H, Sumino Y, and Fujino M. Tissue distribution of prolactin-releasing peptide (PrRP) and its receptor. Regul Pept 83: 1-10, 1999.
8. Gardner JD, Rothwell NJ, and Luheshi GN. Leptin affects food intake via CRF-receptor-mediated pathways. Nat Neurosci 1: 103, 1998.
9. Grill HJ, Ginsberg AB, Seeley RJ, and Kaplan JM. Brainstem application of melanocortin receptor ligands produces long-lasting effects on feeding and body weight. J Neurosci 18: 10128-10135, 1998.
10. Gulyas J, Rivier C, Perrin M, Koerber SC, Sutton S, Corrigan A, Lahrichi SL, Craig AG, Vale W, and Rivier J. Potent, structurally constrained agonists and competitive antagonists of corticotropin-releasing factor. Proc Natl Acad Sci USA 92: 10575-10579, 1995.
11. Haynes WG, Morgan DA, Djalali A, Sivitz WI, and Mark AL. Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33: 542-547, 1999.
12. Heinrichs SC, Li DL, and Iyengar S. Corticotropin-releasing factor (CRF) or CRF binding-protein ligand inhibitor administration suppresses food intake in mice and elevates body temperature in rats. Brain Rev 900: 177-185, 2001.
13. Heinrichs SC and Richard D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides 33: 350-359, 1999.
14. Heisler LK, Cowley MA, Tecott LH, Fan W, Low MJ, Smart JL, Rubinstein M, Tatro JB, Marcus JN, Holstege H, Lee CE, Cone RD, and Elmquist JK. Activation of central melanocortin pathways by fen-fluramine. Science 297: 609-611, 2002.
15. Hinuma S, Habata Y, Fujii R, Kawamata Y, Hosoya M, Fukusumi S, Kitada C, Masuo Y, Asano T, Matsumoto H, Sekiguchi M, Kurokawa T, Nishimura O, Onda H, and Fujino M. A prolactin-releasing peptide in the brain. Nature 393: 272-276, 1998.
16. Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G. and Steiner RA. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction. Am J Physiol Regul Integr Comp Physiol 278: R50-R59, 2000.
17. Hsu SY and Hsueh AJ. Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor. Nat Med 7: 605-611, 2001.
18. Iijima N, Kataoka Y, Kakihara K, Bamba H, Tamada Y, Hayashi S, Matsuda T, Tanaka M, Honjyo H, Hosoya M, Hinuma S, and Ibata Y. Cytochemical study of prolactin-releasing peptide (PrRP) in the rat brain. Neuroreport 10: 1713-1716, 1999.
19. Jarry H, Heuer H, Schomburg L, and Bauer K. Prolactin-releasing peptides do not stimulate prolactin release in vivo. Neuroendocrinology, 71: 262-267, 2000.
20. Jones DN, Kortekaas R, Hatcher PD, Middlemiss DN, White A, and Hagan JJ. Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF. Eur J Pharmacol 373: 141-145, 1999.
21. Koob GF and Heinrichs SC. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res 848: 141-152, 1999.
22. Lawrence CB, Celsi F, Brennand J, and Luckman SM. Alternative role for prolactin-releasing peptide in the regulation of food intake. Nat Neurosci 3: 645-646, 2000.
23. Lawrence CB, Ellacott KL, and Luckman SM. PRL-releasing peptide reduces food intake and may mediate satiety signaling. Endocrinology 143: 360-367, 2002.
24. Lawrence CB and Rothwell NJ. Anorexic but not pyrogenic actions of interleukin-I are modulated by central melanocortin-3/4 receptors in the rat. J Neuroendocrinol 13: 490-495, 2001.
25. Lawrence CB, Snape AC, Baudoin FM, and Luckman SM. Acute central ghrelin and GH secretagogues induce feeding and activate brain appetite centers. Endocrinology 143: 155-162, 2002.
26. Lee Y, Yang SP, Soares MJ, and Voogt JL. Distribution of prolactin-releasing peptide mRNA in the rat brain. Brain Res Bull 51: 171-176, 2000.
27. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, and Vale WW. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 98: 7570-7575, 2001.
28. Lin SH, Leslie FM, and Civelli O. Neurochemical properties of the prolactin releasing peptide (PrRP) receptor expressing neurons: evidence for a role of PrRP as a regulator of stress and nociception. Brain Res 952: 15-30, 2002.
29. Luheshi GN, Gardner JD, Rushforth DA, Loudon AS, and Rothwell NJ. Leptin actions on food intake and body temperature are mediated by IL-I. Proc Natl Acad Sci USA 96: 7047-7052, 1999.
30. Maruyama M, Matsumoto H, Fujiwara K, Kitada C, Hinuma S, Onda H, Fujino M, and Inoue K. Immunocytochemical localization of prolactin-releasing peptide in the rat brain. Endocrinology 140: 2326-2333, 1999.
31. Matsumoto H, Maruyama M, Noguchi J, Horikoshi Y, Fujiwara K, Kitada C, Hinuma S, Onda H, Nishimura O, Inoue K, and Fujino M. Stimulation of corticotropin-releasing hormone-mediated adrenocorticotropin secretion by central administration of prolactin-releasing peptide in rats. Neurosci Lett 285: 234-238, 2000.
32. Matsumoto H, Noguchi J, Horikoshi Y, Kawamata Y, Kitada C, Hinuma S, Onda H, Nishimura O, and Fujino M. Stimulation of prolactin release by prolactin-releasing peptide in rats. Biochem Biophys Res Commun 259: 321-324, 1999.
33. Minami S, Nakata T, Tokita R, Onodera H, and Imaki J. Cellular localization of prolactin-releasing peptide messenger RNA in the rat brain. Neurosci Lett 266: 73-75, 1999.
34. Okamoto S, Kimura K, and Saito M. Anorectic effect of leptin is mediated by hypothalamic corticotropin-releasing hormone, but not by urocortin, in rats. Neurosci Lett 307: 179-182, 2001.
35. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. San Diego, CA: Academic, 1986.
36. Perrin MH, Sutton SW, Cervini LA, Rivier JE, and Vale WW. Comparison of an agonist, urocortin, and an antagonist, astressin, as radioligands for characterization of corticotropin-releasing factor receptors. J Pharmacol Exp Ther 288: 729-734, 1999.
37. Perrin MH and Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 885: 312-328, 1999.
38. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, and Sawchenko PE. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 98: 2843-2848, 2001.
39. Roland BL, Sutton SW, Wilson SJ, Luo L, Pyati J, Huvar R, Erlander MG, and Lovenberg TW, Anatomical distribution of prolactin-releasing peptide and its receptor suggests additional functions in the central nervous system and periphery. Endocrinology 140: 5736-5745, 1999.
40. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, Abusnana S, Goldstone AP, Russell SH, Stanley SA, Smith DM, Yagaloff K, Ghatei MA, and Bloom SR. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology 139: 4428-4431, 1998.
41. Rothwell NJ. Central effects of CRF on metabolism and energy balance. Neurosci Biobehav Rev 14: 263-271, 1990.
42. Samson WK, Keown C, Samson CK, Samson HW, Lane B, Baker JR, and Taylor MM. Prolactin-releasing peptide and its homolog RFRP-1 act in hypothalamus but not in anterior pituitary gland to stimulate stress hormone secretion. Endocrine 20: 59-66, 2003.
43. Samson WK, Resch ZT, and Murphy TC. A novel action of the newly described prolactin-releasing peptides: cardiovascular regulation. Brain Res 858: 19-25, 2000.
44. Samson WK, Resch ZT, Murphy TC, and Chang JK. Gender-biased activity of the novel prolactin releasing peptides: comparison with thyrotropin releasing hormone reveals only pharmacologic effects. Endocrine 9: 289-291, 1998.
45. Satoh N, Ogawa Y, Katsuura G, Numata Y, Masuzaki H, Yoshimasa Y, and Nakao K. Satiety effect and sympathetic activation of leptin are mediated by hypothalamic melanocortin system. Neurosci Lett 249: 107-110, 1998.
46. Seal LJ, Small CJ, Dhillo WS, Kennedy AR, Ghatei MA, and Bloom SR. Prolactin-releasing peptide releases corticotropin-releasing hormone and increases plasma adrenocorticotropin via the paraventricular nucleus of the hypothalamus. Neuroendocrinology 76: 70-78, 2002.
47. Seal LJ, Small CJ, Dhillo WS, Stanley SA, Abbott CR, Ghatei MA, and Bloom SR. PRL-releasing peptide inhibits food intake in male rats via the dorsomedial hypothalamic nucleus and not the paraventricular hypothalamic nucleus. Endocrinology 142: 4236-4243, 2001.
48. Seal LJ, Small CJ, Kim MS, Stanley SA, Taheri S, Ghatei MA, and Bloom SR. Prolactin releasing peptide (PrRP) stimulates luteinizing hormone (LH) and follicle stimulating hormone (FSH) via a hypothalamic mechanism in male rats. Endocrinology 141: 1909-1912, 2000.
49. Seeley RJ, Yagaloff KA, Fisher SL, Burn P, Thiele TE, van Dijk G, Baskin DG, and Schwartz MW. Melanocortin receptors in leptin effects. Nature 390: 349, 1997.
50. Skelton KH, Owens MJ, and Nemeroff CB. The neurobiology of urocortin. Regul Pept 93: 85-92, 2000.
51. Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, and Koob GF. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 273: 1561-1564, 1996.
52. Stock MJ. An automatic, closed-circuit oxygen consumption apparatus for small animals. J Appl Physiol 39: 849-850, 1975.
53. Swanson LW, Sawchenko PE, Rivier J, and Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 36: 165-186, 1983.
54. Tokita R, Nakata T, Katsumata H, Konishi S, Onodera H, Imaki J, and Minami S. Prolactin secretion in response to prolactin-releasing peptide and the expression of the prolactin-releasing peptide gene in the medulla oblongata are estrogen dependent in rats. Neurosci Lett 276: 103-106, 1999.
55. Tsujii S and Bray GA. Acetylation alters the feeding response to MSH and β-endorphin. Brain Res Bull 23: 165-169, 1989.
56. Turnbull AV and Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 215: 1-10, 1997.
57. Uehara Y, Shimizu H, Ohtani K, Sato N, and Mori M. Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin. Diabetes 47: 890-893, 1998.
58. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C, and. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 378: 287-292, 1995.
59. Vergoni AV, Watanobe H, Guidetti G, Savino G, Bertolini A, and Schioth HB. Effect of repeated administration of prolactin releasing peptide on feeding behavior in rats. Brain Res 955: 207-213, 2002.
60. Yamakawa K, Kudo K, Kanba S, and Arita J. Distribution of prolactin-releasing peptide-immunoreactive neurons in the rat hypothalamus. Neurosci Lett 267: 113-116. 1999.